University of Washington: Sexually Transmitted Diseases trials

The registry lists 16 Sexually Transmitted Diseases studies with University of Washington as lead sponsor. 3 are open to participants now and 3 have results posted.

Phase 1 1Phase 2 1Phase 3 5Phase 4 4No phase 5(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Sexual Health Access at Retail Pharmacies: Advancing Pharmacy-based Delivery of Primary STI and HIV Prevention for Cisgender WomenNot yet recruitingNCT07361926Not applicable
• "Sexual Health Assessment of TinidaZole Against M. Genitalium (SHAZAM)"RecruitingNCT07088419Phase 2
• Improving Perinatal Outcomes Among Kenyan Pregnant Women With an Integrated STI Testing ModelRecruitingNCT06203951Not applicable
• Weekly Doxycycline DOT for STI Prevention Among Cisgender Women Taking HIV PrEP in Kisumu, KenyaCompletedNCT06582966Phase 4Results posted
• Alignment of PrEP Use With HIV Risk in Young Women and MenCompletedNCT04664998Phase 4Results posted
• Doxycycline PEP for Prevention of Sexually Transmitted Infections Among Kenyan Women Using HIV PrEPCompletedNCT04050540Phase 4Results posted
• BIYELA - Bexsero Immunisation in Young Women in AfricaActive, not recruitingNCT06446752Phase 3
• PrEParing Family Planning Clinics to Streamline Integration of HIV Prevention Services for Young Women in KenyaCompletedNCT04666792Phase 4
• Peer Intervention Latino Immigrant MSMCompletedNCT03922126Not applicable
• eKISS: Electronic KIOSK Intervention for Safer-SexCompletedNCT03027531Not applicable
• The Community Youth Development Study: A Test of Communities That CareActive, not recruitingNCT01088542Not applicable
• 62% & 15% Ethanol in Emollient Gel as Topical Male MicrobicidesCompletedNCT00469547Phase 1
• HSV-2 Suppression to Reduce HIV-1 Levels in HIV-1 Co-infected PersonsCompletedNCT00465205Phase 3
• HSV-2 Suppression to Reduce HIV-1 Levels in HIV-1, HSV-2 Co-infected Men.CompletedNCT00378976Phase 3
• Herpes Simplex Virus Type 2 (HSV-2) Suppression to Prevent HIV TransmissionCompletedNCT00194519Phase 3
• Reducing Vaginal Infections in WomenCompletedNCT00170430Phase 3